RAPID AND SUSTAINED IMPROVEMENTS IN BOTH SKIN AND MUSCULOSKELETAL SYMPTOMS CORRELATES WITH IMPROVED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kavanaugh, A. F. [1 ]
Birt, J. [2 ]
Lin, C. -Y. [2 ]
Benichou, O. [3 ]
Hufford, M. [2 ]
Gottlieb, A. B. [4 ]
机构：
[1] Univ CA San Diego Hlth Syst, La Jolla, CA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Paris, France
[4] New York Med Coll, New York, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2331
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0316
引用
收藏
页码：1022 / 1022
页数：1
相关论文
共 50 条
  • [31] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    Nash, P.
    McInnes, I. B.
    Rahman, P.
    Gottlieb, A. B.
    Kirkham, B.
    Ding, K.
    Pricop, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 379 - 379
  • [32] Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studies
    Merola, J. F.
    Papp, K. A.
    Nash, P.
    Gratacos, J.
    Boehncke, W. H.
    Thaci, D.
    Graham, D.
    Hsu, M-A
    Wang, C.
    Wu, J.
    Young, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : 2809 - 2820
  • [33] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Tahir, Hasan
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pascale, Pellet
    Delicha, Evie Maria
    Pricop, Luminita
    Mpofu, Shephard
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] SUSTAINED IMPROVEMENTS IN SKIN OUTCOMES FOLLOWING CERTOLIZUMAB PEGOL TREATMENT OF PSORIATIC ARTHRITIS PATIENTS WITH PRIOR ANTI-TNF EXPOSURE OR SEVERE SKIN INVOLVEMENT AT BASELINE
    Khraishi, M.
    Hoepken, B.
    Davies, O.
    Arledge, T.
    Peterson, L.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 353 - 354
  • [35] Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Psoriatic Arthritis: Pooled Results from the Secukinumab Phase 3 Trial Program
    Strand, Vibeke
    FitzGerald, Oliver
    Coates, Laura C.
    Walsh, Jessica
    Canete, Juan A.
    Nash, Peter
    Davenport, Eric
    Pricop, Luminita
    Hustache, Gregory
    Scheuer, Nicolas
    Gilloteau, Isabelle
    Augustin, Matthias
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Rapid and sustained improvements in cutaneous and musculo-skeletal signs and symptoms with 108 weeks treatment of ixekizumab in psoriatic arthritis in biologic-naive and TNF-inadequate responder patients
    Gottlieb, Alice B.
    Merola, Joseph F.
    Shrom, David
    Sprabery, Aubrey T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB262 - AB262
  • [37] Achievement of Minimal Disease Activity Is Associated with Improvements in Health-Related Quality of Life and Productivity in Psoriatic Arthritis Patients
    Coates, Laura C.
    Orbai, Ana-Maria
    Birt, Julie
    Kerr, Lisa
    Benichou, Olivier
    Helliwell, Philip S.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Improvements in Quality of Life and Functional Status in Patients With Psoriatic Arthritis Receiving Anti-Tumor Necrosis Factor Therapies
    Saad, Amr A.
    Ashcroft, Darren M.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Noyce, Peter R.
    Hyrich, Kimme L.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (03) : 345 - 353
  • [39] Rapid and sustained improvements in patient-reported outcomes with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis
    Hasan, Tahir
    Haschemi, Nassab Mani
    Andrew, Bradley
    Georg, Pum
    Katrien, Van Beneden
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [40] RAPID AND SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH IXEKIZUMAB IN BIOLOGIC-NAIVE AND TNF-INADEQUATE RESPONDER PATIENTS WITH PSORIATIC ARTHRITIS
    Tahir, Hasan
    Nassab, Mani Haschemi
    Bradley, Andrew
    Pum, Georg
    Van Beneden, Katrien
    RHEUMATOLOGY, 2019, 58
12345